AI model boosts cancer gene prediction and patient prognosis

FHS
July 12, 2024
4:28 am

The artificial intelligence (AI) model GPT-4, known from its application in ChatGPT, shows impressive capabilities in biomedical research and can be used in many ways for simulations. A simulator developed at MedUni Vienna and based on GPT-4 shows increased accuracy in classifying the importance of genes in cancer cells, as well as in the prognosis of cancer patients. The results of the study were published in the journal Computers in Biology and Medicine.

Two genomics powerhouses team up to expand infectious disease surveillance

LONDON — Two research centers that have been at the forefront of following the evolution of the SARS-CoV-2 coronavirus — one in the U.K. and

January 25, 2024

Clasp Therapeutics emerges with $150M based on work from Bert Vogelstein, Drew Pardoll

Researchers at Johns Hopkins University have launched another biotech that builds on more than a decade of investigation that they hope will improve T cell

March 21, 2024

VCs move to launch U.S.-based companies to develop drugs developed in China

As Chinese biopharma companies rise on the international stage, they are increasingly finding VC partners — in the United States. U.S. companies have long signed

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.